October 4th 2025
Artificial intelligence, machine learning, and novel instruments are helping drug developers evaluate complex data from bioanalytical studies.
Method Validation by Design to Support Formulation Development
April 2nd 2013The authors describe a method-validation-by-design (MVbD) approach to validate a method over a range of formulations using both design-of-experiment and quality-by-design principles to define a design space that allows for formulation changes without revalidation.